Investigation of the Efficacy and Safety of Topical Vibration Anesthesia to Reduce Pain From Cosmetic Botulinum Toxin A Injections in Chinese Patients: A Multicenter, Randomized, Self-Controlled Study

被引:10
|
作者
Li, Yiming [1 ,2 ]
Dong, Weiwei [2 ]
Wang, Min [3 ]
Xu, Ning [4 ]
机构
[1] Huaxi Hosp, Dept Dermatol & Venereol, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan FreSkin Hosp, Dept Dermatol, Chengdu, Sichuan, Peoples R China
[3] Xian FreSkin Hosp, Dept Dermatol, Xian, Shaanxi, Peoples R China
[4] Chongqing FreSkin Hosp, Dept Dermatol, Chongqing, Peoples R China
关键词
GATE CONTROL; MANAGEMENT; THERAPY;
D O I
10.1097/DSS.0000000000001349
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND Vibration has been proved to be effective to reduce pain during facial cosmetic injections, but it has not been studied in Chinese patients. OBJECTIVE To investigate the efficacy and safety of vibration for pain reduction associated with cosmetic botulinum toxin A (BTX-A) injections in Chinese patients. MATERIALS AND METHODS In this prospective, randomized, split-face and right-left, self-controlled study, 53 patients received BTX-A injections for rhytid reduction, lower face, shoulder, and leg reshaping. Injections were given in a split-face and right-left design randomly assigned. A vibration stimulus was coadministered with BTX-A injections on one side, whereas the other side received BTX-A injections only. Patients completed a questionnaire immediately after treatment and were followed up 2 weeks later. A visual analog scale of pain sensation was statistically analyzed. RESULTS The patients experienced both clinically and statistically significant pain reduction when a vibration was coadministered with injections. Patients reported less pain on the treated side compared with the control side. Overall, 75% of patients preferred to receive vibration with their next treatment. No adverse events were reported. CONCLUSION Vibration is an effective and safe way to reduce pain during cosmetic BTX-A injections and may have applications in other cosmetic procedures.
引用
收藏
页码:S329 / S335
页数:7
相关论文
共 12 条
  • [1] Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter study
    Ernberg, Malin
    Hedenberg-Magnusson, Britt
    List, Thomas
    Svensson, Peter
    PAIN, 2011, 152 (09) : 1988 - 1996
  • [2] Efficacy and Safety of Diclofenac plus Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study
    Predel, Hans-Georg
    Ebel-Bitoun, Caty
    Peil, Barbara
    Weiser, Thomas W.
    Lange, Robert
    PAIN AND THERAPY, 2020, 9 (01) : 279 - 296
  • [3] Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Senet, Patricia
    Maillard, Herve
    Diot, Elisabeth
    Lazareth, Isabelle
    Blaise, Sophie
    Arnault, Jean-Philippe
    Pistorius, Marc-Antoine
    Boulon, Carine
    Cogrel, Olivier
    Warzocha, Ursula
    Riviere, Sebastien
    Malloizel-Delaunay, Julie
    Servettaz, Amelie
    Sassolas, Bruno
    Viguier, Manuelle
    Monfort, Jean-Benoit
    Janique, Solene
    Vicaut, Eric
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (03) : 459 - 467
  • [4] A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia
    Xu, Shaoyong
    Liu, Xiangyang
    Ming, Jie
    Chen, Shenren
    Wang, Yangang
    Liu, Xiumei
    Liu, Hong
    Peng, Yongde
    Wang, Jianqin
    Lin, Jinying
    Ji, Haiwang
    Liu, Bin
    Lu, Ying
    Liu, Peng
    Zhang, Yonghong
    Ji, Qiuhe
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2015, 18 (06) : 669 - 678
  • [5] Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double- blind, placebo-controlled study
    Wang, G.
    Bi, L.
    Li, X.
    Li, Z.
    Zhao, D.
    Chen, J.
    He, D.
    Wang, C. -N.
    Duenas, H.
    Skljarevski, V.
    Yue, L.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (06) : 832 - 838
  • [6] Safety and efficacy of pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis: a multicenter, double-blind, placebo-controlled, randomized study
    Kasyan, George
    Kupriyanov, Yury
    Karasev, Alexander
    Baibarin, Kirill
    Pushkar, Dmitry
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2021, 74 (02) : 201 - 207
  • [7] Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
    Li, Xiaoxin
    Wang, Ningli
    Liang, Xiaoling
    Xu, Gezhi
    Li, Xiao-Yan
    Jiao, Jenny
    Lou, Jean
    Hashad, Yehia
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 59 - 69
  • [8] A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain
    Katz, Nathaniel
    Kopecky, Ernest A.
    O'Connor, Melinda
    Brown, Robert H.
    Fleming, Alison B.
    PAIN, 2015, 156 (12) : 2458 - 2467
  • [9] Safety and Efficacy of Once-Daily Hydromorphone Extended-Release Versus Twice-Daily Oxycodone Hydrochloride Controlled-Release in Chinese Patients With Cancer Pain: A Phase 3, Randomized, Double-Blind, Multicenter Study
    Yu, Shiying
    Shen, Wei
    Yu, Lu
    Hou, Yanyan
    Han, John
    Richards, Henry M.
    JOURNAL OF PAIN, 2014, 15 (08) : 835 - 844
  • [10] Efficacy and safety of ferric citrate on hyperphosphatemia among Chinese patients with chronic kidney disease undergoing hemodialysis: a phase III multicenter randomized open-label active-drug controlled study
    Wang, Yong
    Chen, Xiangmei
    Zhu, Hanyu
    Guo, Zhiyong
    Yang, Yibin
    Luo, Ping
    He, Yani
    Xu, Yan
    Ji, Daxi
    Gao, Xinlu
    Sun, Xiuli
    Xing, Changying
    Wang, Yu
    Wang, Xiaohui
    Zhao, Shuping
    Guan, Yan
    Lin, Hongli
    Zhong, Aimin
    Shui, Hua
    Shao, Fengmin
    Lv, Lu
    Yan, Yuehong
    Sun, Xiaokun
    Zhang, Lei
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (11-12) : 479 - 488